24812-89-3 Usage
Uses
Used in Organic Synthesis:
Methyl 3-amino-2,4-dimethylbenzoate is used as a reagent in organic synthesis for its ability to participate in various chemical reactions due to the presence of both amino and ester functional groups.
Used in Pharmaceutical Industry:
Methyl 3-amino-2,4-dimethylbenzoate is used as an intermediate in the synthesis of pharmaceutical compounds, contributing to the development of new drugs and medications.
Used in Chemical Research:
Methyl 3-amino-2,4-dimethylbenzoate is used as a research compound in academic and industrial laboratories, aiding in the exploration of new chemical reactions and the discovery of novel chemical properties.
Used in Material Science:
Methyl 3-amino-2,4-dimethylbenzoate is used as a component in the development of new materials, such as polymers and composites, due to its unique chemical structure and reactivity.
Used in Environmental Applications:
Methyl 3-amino-2,4-dimethylbenzoate is used in the development of environmentally friendly processes and products, such as green chemistry initiatives and sustainable technologies, to minimize its ecological footprint.
Check Digit Verification of cas no
The CAS Registry Mumber 24812-89-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,8,1 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 24812-89:
(7*2)+(6*4)+(5*8)+(4*1)+(3*2)+(2*8)+(1*9)=113
113 % 10 = 3
So 24812-89-3 is a valid CAS Registry Number.
24812-89-3Relevant academic research and scientific papers
Blanco, Maria-Jesus,Vetman, Tatiana,Chandrasekhar, Srinivasan,Fisher, Matthew J.,Harvey, Anita,Mudra, Daniel,Wang, Xu-Shan,Yu, Xiao-Peng,Schiffler, Matthew A.,Warshawsky, Alan M.
, p. 105 - 109 (2016)
A novel series of EP4 antagonists, based on a quinoline scaffold, has been discovered. Medicinal chemistry efforts to optimize the potency of the initial hit are described. A highly potent compound in a clinically relevant human whole blood assay was iden
DIMETHYLBENZOIC ACID COMPOUNDS
-
Page/Page column 9-10, (2015/07/07)
The present invention provides a compound of the Formula I: wherein A is: and W, Y, X, R1, R2, R3, and R4 are as defined herein, or a pharmaceutically acceptable salt thereof, for use as an inhibitor of the EP4 receptor.
DIMETHYL-BENZOIC ACID COMPOUNDS
-
Page/Page column 17; 18, (2014/01/17)
The present invention provides a compound of the Formula II: wherein A is: * R 1 is CH3, CF 3, or F; * R 2 is H, CH3, or F; * R 3 is CH3, OCH 3, OH, F; R 4 is OH or CH 20H; and *
